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Abstract
Background: The heterogeneity of symptoms across dementia subtypes has important implications for clinical
practice and dementia research. Variation in subtypes and associated symptoms may influence the capability to live
well for people with dementia and carers. The aim of this study is to investigate the potential impact of dementia
subtypes on the capability to live well for both people with dementia and their carers.
Methods: The analysis was based on the 1283 dyads of community-dwelling people with dementia and carers in
the Improving the experience of Dementia and Enhancing Active Life (IDEAL) project, a large cohort study in Great
Britain. Capability to live well was defined using three measures: quality of life, life satisfaction and wellbeing.
Structural equation modelling was used to investigate capability to live well in seven dementia subtypes: Alzheimer’s
disease (AD), Vascular dementia (VaD), mixed AD/VaD, frontotemporal dementia (FTD), Parkinson’s disease dementia
(PDD), Lewy body dementia (LBD) and unspecified/other, accounting for dyadic data structure and adjusting for age
and sex, type of relationship between person with dementia and their carer and the number of chronic conditions.
Results: The major subtypes in this study population were AD (56%), VaD (11%) and mixed AD/VaD (21%). Compared
to participants with AD, people with non-AD subtypes generally reported a lower capability to live well. Carers for
people with PDD (− 1.71; 95% confidence interval (CI) – 3.24, − 0.18) and LBD (− 2.29; 95% CI – 3.84, − 0.75) also
reported a lower capability to live well than carers for people with AD. After adjusting for demographic factors
and comorbidity, PDD (− 4.28; 95% CI – 5.65, − 2.91) and LBD (− 3.76; 95% CI – 5.14, − 2.39) continued to have the
strongest impact on both people with dementia and their carers.
Conclusions: This study suggests a variation in capability to live well across dementia subtypes. It is important
for care providers to consider different needs across subtypes. Health professionals who provide post-diagnostic
support may need to pay more attention to the complex needs of people living with PDD and LBD and
their carers.
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Background
Dementia is a key priority area in health and social
care planning across the world, with an increasing em-
phasis on timely diagnosis and appropriate support
throughout the trajectory of the condition [1, 2]. To
support the large number of people living with demen-
tia and their carers to live well and manage the condi-
tion, provision of effective post-diagnostic care has
become an important issue for health services and
clinical practice [3]. For example, in the UK the
current National Health Service (NHS) strategy to im-
prove dementia care includes encouraging general
practitioners to play a leading role in the coordination
and continuity of care for people with dementia [4].
Yet there is a lack of evidence-based guidance to en-
able health professionals to identify high-risk groups
who might experience poor quality of life due to
dementia-related symptoms and need additional sup-
port to live well with their condition.
Living well with chronic illness has been defined as
the best achievable state of physical, mental and social
health and wellbeing, indexed by a self-perceived level
of comfort, function and contentment with life [5].
The concept of ‘living well’ with dementia has been
largely equated to a good quality of life. However, liv-
ing well can mean more than a score on quality of life
measured at a specific time point. The concept should
encompass other inter-related constructs such as the
experience of satisfaction with life and a sense of sub-
jective wellbeing [6].
The heterogeneity of symptoms across dementia sub-
types has been a key topic in clinical practice and relevant
research [7, 8]. Variation in the symptoms associated with
different subtypes may influence quality of life and well-
being in people with dementia and their carers. Needs for
post-diagnostic support and care may also vary across dif-
ferent subtypes. Indeed, previous studies have highlighted
the potential impact of dementia subtypes on quality of
life in people with dementia and on the burden of caregiv-
ing. Compared to Alzheimer’s disease (AD), people with
Lewy body dementia (LBD) tend to report a worse quality
of life [9–11]. Family carers for people with fronto-
temporal dementia (FTD) and LBD have been found
to experience a greater caregiving burden than carers
for people with AD [11–13]. However, most existing
studies were based on a relatively small number of
participants recruited from clinical or residential set-
tings and focused on specific subtypes and variation
in people with dementia or carers separately. To ad-
dress limitations in the existing studies, the aim of
this study is to investigate the potential impact of de-
mentia subtypes on the capability to live well using
1283 dyads of community-dwelling people with de-
mentia and their carers in Great Britain.
Methods
Study population
The Improving the experience of Dementia and Enhan-
cing Active Life (IDEAL) project is a longitudinal cohort
study of community-dwelling people with dementia and
their carers across England, Scotland and Wales. The
study was set up to investigate social, psychological and
economic factors that support people living well with
dementia. The participants were recruited through a net-
work of 29 NHS sites between July 2014 and August
2016. Eligible participants needed to have a clinical diag-
nosis of dementia and a Mini-Mental State Examination
(MMSE) score of 15 or above on entry into the study.
Primary carers, who provided practical or emotional un-
paid support for people with dementia, were also invited
to take part where possible. For those who agreed to
take part, researchers visited participants and completed
structured interviews to collect data. The study protocol
has been published elsewhere [14]. The IDEAL study
was approved by the Wales Research Ethics Committee
5 (reference 13/WA/0405) and the Ethics Committee of
the School of Psychology, Bangor University (reference
2014-11684). IDEAL is registered with the UK Clinical
Research Network, number 16593.
The IDEAL cohort at baseline included 1547 people
with dementia and 1283 carers. This analysis focused on
the 1283 dyads of person with dementia and their carer.
Measurements
Capability to live well was defined using three individual
measures for quality of life, life satisfaction and well-
being for the person with dementia and the carer. For
people with dementia, self-rated life satisfaction was
measured by the Satisfaction with Life Scale (SwLS;
score range 5–35), which is designed to measure global
judgements of satisfaction with life [15]; wellbeing was
measured by the World Health Organization Five
Well-being Index (WHO-5; score range 0–100), which
includes items on positive mood, vitality and general in-
terests [16]; and quality of life was measured by the
Quality of Life in Alzheimer’s Disease (QOL-AD; score
range 13–52), which is a dementia-specific measure of
quality of life, incorporating multiple aspects of mood,
health status, interpersonal relationships and financial
situation [17]. The same measures for life satisfaction
and wellbeing were used in the carer interview, but qual-
ity of life was measured using the World Health
Organization Quality of Life-Brief (WHOQOL-BREF),
which includes two single indicators (overall quality of
life and general health) and four domains (physical
health, psychological health, social relationships and en-
vironment) [18]. WHOQOL-BREF is designed to meas-
ure multiple components related to quality of life and
does not have a total score. To provide an overall score
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for quality of life in carers, a factor analysis was con-
ducted to estimate factor scores for those with complete
data. The mean and standard deviation (SD) of the
WHOQOL-BREF factor score was 0.0 (SD = 2.1) with a
range between − 7.9 and 4.7. More detailed information
is provided in Additional file 1.
The interviews collected information on age, sex, de-
mentia subtypes and the type of relationship between
the person with dementia and the carer. Age was divided
into five groups: < 65, 65–69, 70–74, 75–79 and ≥ 80 for
both people with dementia and carers. Dementia diagno-
ses were obtained from medical records of the partici-
pants and classified in seven groups: Alzheimer’s disease
(AD), vascular dementia (VaD), mixed AD and VaD,
frontotemporal dementia (FTD), Parkinson’s disease de-
mentia (PDD), Lewy body dementia (LBD) and other/
unspecified. For those who selected other or an unspeci-
fied diagnosis in the interviews, open-ended text descrip-
tions provided by the interviewer were reviewed by two
clinicians and re-categorised into the six empirical groups
where possible. The type of relationship between the per-
son with dementia and carer was categorised into two
groups: spouse/partner and family/friend such as daugh-
ters, sons and grandchildren. Due to the small numbers of
friends serving as carers (N = 12), this group was com-
bined with family carers. As poor health status has been
related to poor quality of life and wellbeing, the number
of chronic conditions was used to indicate the general
physical health of people with dementia and was mea-
sured using the Charlson Comorbidity Index [19].
Analytical strategy
Before conducting the dyadic analysis, the associations
between subtypes and the three living well measures in
people with dementia and carers were investigated using
multivariate modelling. Structural equation modelling
(SEM) was used to build two latent factors including
three living well measures in people with dementia
(SwLS, WHO-5 and QOL-AD) and carers (SwLS,
WHO-5 and WHOQOL-BREF factor score), and SwLS
was fixed at 1 in the latent factors. Covariance of their
error terms was estimated to account for the dyadic
structure (Fig. 1). The dyadic relationships between sub-
types and living well latent factors (P and C in Fig. 1)
were also examined in SEM adjusting for the age and
sex of people with dementia and carers as well as the
type of relationship between persons with dementia and
their carers. Further adjustment for number of chronic
conditions was conducted to account for physical health
conditions in people with dementia. The estimation
method of maximum likelihood with missing values was
used in the modelling in order to account for missing
data [20]. To investigate whether the associations be-
tween dementia subtypes and capability to live well were
different in those without carers, a sensitivity analysis
was conducted to test the model in all IDEAL partici-
pants (N = 1547). This study was based on the IDEAL
baseline data version 2.0. All analyses were conducted
using Stata 14.2.
Results
Descriptive information on the 1283 dyads is reported in
Table 1. The median age was 77 (interquartile range
(IQR) = 12.0) for people with dementia and 71 (IQR =
14.0) for carers. More than half of people with dementia
were men, while nearly 70% of the carers were women.
Most carers were spouses or partners (81%) of the per-
son with dementia. Nearly 56% of the participants had
AD, 11% had VaD and 21% had a diagnosis of mixed AD
and VaD. A relatively small percentage of participants
Fig. 1 Dyadic relationship between subtypes and capability to live well in people with dementia (P) and carers (C)
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had FTD (3.5%), PDD (3.4%) and LBD (3.4%); the
other/unspecified category accounted for 2.5%. The
median MMSE score of people with dementia was
23 (IQR = 6.0), and 27% of people with dementia and
22% of the carers had no educational qualification.
Approximately one-third of people with dementia
(35%) and carers (30%) reported fair or poor self-
rated health.
Table 2 reports the means and standard deviations of
the three living well measures in people with dementia
and carers across subtypes. People with dementia gener-
ally reported higher scores for life satisfaction and well-
being than their carers, but the patterns across subtypes
were similar in people with dementia and carers. The
mean scores were generally higher in AD and lower in
PDD and LBD.
Table 1 Descriptive information on the study population (N = 1283)
People with dementia: N(%) Carers: N(%)
Age
80+ 482 (37.6) 216 (16.8)
75–79 306 (23.9) 223 (17.4)
70–74 232 (18.1) 267 (20.8)
65–69 160 (12.5) 208 (16.2)
< 65 103 (8.0) 369 (28.8)
Sex
Men 755 (58.9) 402 (31.3)
Women 528 (41.1) 881 (68.7)
Dementia subtype
Alzheimer’s disease (AD) 715 (55.7)
Vascular dementia (VaD) 142 (11.1)
Mixed AD and VaD 263 (20.5)
Frontotemporal dementia (FTD) 45 (3.5)
Parkinson’s disease dementia (PDD) 43 (3.4)









Table 2 Mean scores and standard deviation of living well measures in people with dementia and carers across subtypes
People with dementia Carers
SwLS WHO-5 QOL-AD SwLS WHO-5 WHOQOL-BREFa
AD 27.3 (5.5) 64.2 (19.5) 37.7 (5.5) 24.1 (6.4) 56.6 (19.6) 0.1 (2.0)
VaD 25.6 (6.3) 58.6 (21.2) 35.9 (6.5) 23.4 (6.3) 53.0 (19.3) −0.1 (2.1)
Mixed AD/VaD 26.3 (5.9) 59.8 (21.0) 36.3 (5.8) 24.4 (6.5) 55.2 (19.9) 0.0 (2.1)
FTD 25.7 (5.9) 61.0 (20.5) 38.7 (5.4) 21.9 (7.2) 53.2 (21.8) −0.2 (2.2)
PDD 22.0 (6.8) 47.9 (20.4) 33.1 (5.7) 21.5 (5.6) 50.1 (19.0) −0.4 (1.8)
LBD 23.7 (5.2) 50.7 (17.8) 33.0 (6.3) 20.4 (7.9) 47.7 (20.9) −0.7 (2.1)
Other 26.2 (7.6) 58.5 (24.8) 34.7 (8.1) 23.2 (6.4) 56.9 (18.3) −0.4 (2.2)
AD Alzheimer’s disease, VaD vascular dementia, FTD frontotemporal dementia, PDD Parkinson’s disease dementia, LBD Lewy body dementia, SwLS Satisfaction with
Life Scale, WHO-5 World Health Organization Five Well-being Index, QOL-AD Quality of Life in Alzheimer’s Disease,
aWHOQOL-BREF factor score estimated from six domains
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In people with dementia, loadings of the living well la-
tent factors (SwLS fixed at 1) were estimated to be 3.82
(95% confidence interval (CI) 3.52, 4.13) for WHO-5
and 1.21 (95% CI 1.12, 1.31) for QOL-AD. In carers,
loading estimates were 3.37 (95% CI 3.11, 3.62) for
WHO-5 and 0.41 (95% CI 0.38, 0.44) for the
WHOQOL-BREF factor score. The two living well latent
factors were correlated, and the estimated covariance
was 5.62 (95% CI 4.22, 7.03).
Table 3 reports dyadic associations between subtypes and
capability to live well in people with dementia and carers (P
and C in Fig. 1). Participants with non-AD subtypes re-
ported a lower capability to live well than those with AD.
Significant differences were found for VaD (− 1.69; 95% CI
– 2.52, − 0.87), mixed AD/VaD (− 1.34; 95% CI – 1.99, −
0.70), PDD (− 4.39; 95% CI – 5.80, − 2.97), LBD (− 3.81;
95% CI – 5.23, − 2.40) and other (− 1.98; 95% CI – 3.59, −
0.38) after adjusting for age, sex and type of relationship.
For carers, the variations across subtypes were relatively
small, but lower capability to live well was also found for
carers of people with PDD (− 1.55; 95% CI – 3.06, − 0.03)
and LBD (− 1.77; 95% CI – 3.29, − 0.25) compared to carers
of people with AD. Further adjustment for the number of
chronic conditions in people with dementia attenuated the
difference in VaD (− 0.96; 95% CI – 1.77, − 0.15) and mixed
AD/VaD (− 0.87; 95% CI – 1.50, − 0.24) for people with de-
mentia, but the effect sizes for PDD and LBD remained
similar in both. The association between subtypes and cap-
ability to live well was similar for all people with dementia,
including those without carers. More detailed information
on the sensitivity analysis is provided in Additional file 1.
Based on the adjusted results, Fig. 2a–c shows esti-
mated scores for the three living well measures across
subtypes in people with dementia and their carers.
Carers had systematically lower scores than people with
dementia, but estimates for SwLS and WHO-5 were
similar in those with PDD and LBD.
Discussion
Main findings
Using dyadic analysis methods, this study suggest a po-
tential impact of subtype diagnosis on capability to live
well in both people with dementia and carers. People
with non-AD subtypes, including VaD, mixed VaD/AD,
PDD and LBD, had a lower capability to live well than
those with AD. For carers, those caring for people with
PDD and LBD reported lower scores on living well mea-
sures than carers of people with AD. Further adjustment
for comorbidity attenuated differences between AD, VaD
and mixed AD/VaD, but PDD and LBD continued to
have a particularly strong impact on capability to live
well in both people with dementia and carers.
Strengths and limitations
The IDEAL study included a large number of
community-dwelling people with dementia and their
carers across Great Britain. In addition to major sub-
types (AD and VaD), people with rare subtypes were also
recruited and were represented by at least 40 dyads in
this study population. The interviews included multiple
measures of living well, including aspects of quality of
life, life satisfaction and wellbeing for both people with
dementia and their carers. The method of dyadic ana-
lysis was used to investigate the association between
subtypes and capability to live well in both people with
dementia and carers and to take into account correla-
tions within dyads.
To be eligible to take part, participants needed to have
a clinical diagnosis of dementia and a MMSE score of 15
or above. People with severe dementia were not included
in the study, and the dyadic association between sub-
types and capability to live well might be different in this
group compared to the current study population focus-
ing on mild to moderate dementia. Given our interest in
the dyadic relationship, this analysis mainly focused on
Table 3 Results of structural equation model: dyadic associations between subtypes and capability to live well in people with
dementia and carers (N = 1283)
Unadjusted Adjusted 1 Adjusted 2
Person with dementia
(P)
Carer (C) Person with dementia
(P)
Carer (C) Person with dementia
(P)
Carer (C)
AD (Reference) (Reference) (Reference) (Reference) (Reference) (Reference)
VaD −1.64 (−2.47, −0.82) −0.72 (−1.62, 0.17) − 1.69 (− 2.52, − 0.87) −0.58 (− 1.47, 0.31) −0.96 (− 1.77, − 0.15) −0.22 (− 1.12, 0.68)
Mixed
AD/VaD
− 1.14 (− 1.78, − 0.50) −0.17 (− 0.87, 0.54) −1.34 (− 1.99, − 0.70) −0.19 (− 0.89, 0.50) −0.87 (− 1.50, − 0.24) 0.05 (− 0.66, 0.75)
FTD −0.13 (− 1.49, 1.23) −0.83 (− 2.34, 0.68) 0.39 (− 0.99, 1.78) −0.30 (− 1.80, 1.20) 0.17 (−1.16, 1.50) −0.42 (− 1.92, 1.07)
PDD −4.26 (−5.68, − 2.85) −1.71 (− 3.24, − 0.18) −4.39 (− 5.80, − 2.97) − 1.55 (− 3.06, − 0.03) − 4.28 (− 5.65, − 2.91) − 1.51 (− 3.02, − 0.01)
LBD −3.72 (− 5.14, − 2.31) −2.29 (− 3.84, − 0.75) − 3.81 (− 5.23, − 2.40) − 1.77 (− 3.29, − 0.25) −3.76 (− 5.14, − 2.39) − 1.77 (− 3.28, − 0.26)
Other − 1.88 (− 3.48, − 0.27) − 0.84 (− 2.61, 0.93) −1.98 (− 3.59, − 0.38) − 0.97 (− 2.72, 0.78) −1.98 (− 3.54, − 0.43) −0.99 (− 2.72, 0.75)
AD Alzheimer’s disease, VaD vascular dementia, FTD frontotemporal dementia, PDD Parkinson’s disease dementia, LBD Lewy body dementia, Adjusted 1 age and
sex in people with dementia and carers, type of relationship between the person with dementia and carer, Adjusted 2 all factors in Adjusted 1 and number of
chronic conditions in people with dementia
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participants with carers. Since those without carers
might have better health status and functional ability
and in some cases might not need a carer, the associ-
ation between subtypes and capability to live well might
be different in this group. Nevertheless, similar results
were found in sensitivity analyses including all partici-
pants irrespective of carer involvement (N = 1547);
therefore, this should have a minimal impact on the
main findings.
The diagnoses of dementia subtypes were made by dif-
ferent clinicians across the country. Variation in clinical
practice and potential diagnostic misclassification could
not be addressed in this analysis. However, a clinical
diagnosis reflects the experience of people with demen-
tia and their carers attending health services and leads
to selection of particular treatments and disease man-
agement plans. Different measures for quality of life
were used in people with dementia and the carers, and
Fig. 2 Estimated scores of living well measures across subtypes (adjusted for age, sex, type of relationship and number of chronic conditions in people with
dementia) (a) Life satisfaction (SwLS) (b) Well-being (WHO-5) (c) Quality of life (QOL-AD) for people with dementia, WHOQOL-BREF factor score for carers
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therefore changes in quality of life scores were not dir-
ectly comparable. To generate an overall score for qual-
ity of life in carers, six independent domains in
WHOQOL-BREF were combined using factor analysis.
Although measures for quality of life were different for
people with dementia and carers, this study mainly fo-
cused on relative differences, and similar patterns were
found in these two quality of life measures.
Interpretation of results
People with non-AD subtypes had a lower capability to
live well than those with AD. When further adjusting for
comorbidity, the difference between AD, VaD and mixed
AD/VaD reduced considerably. This suggests that the
burden of chronic conditions might explain much of the
observed differences across these subtypes. Although the
diagnosis of VaD is based on cerebrovascular pathology
and small vessel disease, people with VaD might also ex-
perience physical disabilities as well as language and
visuospatial deficits due to stroke and heart attack and
thus may have poor quality of life and wellbeing [8].
People with PDD and LBD continued to show a par-
ticularly poor capability to live well, even when we fur-
ther adjusted for the number of chronic conditions. This
corresponds to findings from previous studies [9–11].
These two subtypes are closely related, and the differen-
tial diagnosis is largely based on when symptoms first
appear. The core symptoms of LBD, including fluctuat-
ing cognition, visual hallucinations and spontaneous fea-
tures of Parkinsonism [8], may have a relatively large
impact on daily life compared to the major symptoms of
memory loss in AD. A higher number of autonomic
symptoms such as fatigue, postural dizziness and muco-
sal dryness have also been reported in PDD and LBD
than in AD [21]. PDD is also associated with high co-
morbidity [22, 23], and the mix of physical, emotional
and cognitive changes might have a negative impact on
quality of life for the person with dementia as well as
their carer. Carers of people with PDD and LBD have
been reported to experience a higher level of stress than
carers of those with AD and VaD [24]. This might be
due to the challenges of responding to symptoms such
as hallucinations, motor disability and functional impair-
ment in PDD and LBD [11].
The literature has suggested a greater burden of care
in FTD [12, 13]. FTD generally occurs in younger age
groups (< 65) and includes symptoms related to changes
in personality, behaviour and function [7]. Although
these symptoms may plausibly increase the burden of
caregiving and cause poor quality of life and wellbeing,
this study did not find a difference in the capability to
live well between carers of people with FTD and AD. A
previous study from Australia has reported variation in
caregiving burden across different FTD variants [12].
Although carers of persons with behavioural variant
FTD (bvFTD) did report a particularly high burden,
carers for people with other FTD variants, including se-
mantic dementia and progressive non-fluent aphasia,
had similar levels of burden to carers of people with AD.
Indeed, the mean scores for living well measures were
found to be lower for the 10 IDEAL carers of people
with bvFTD than for carers of people with other FTD
variants. However, it is not possible to test differences
within this subtype based on such a small sample size
and limited statistical power. In addition, this study
population only included those with mild to moderate
dementia and did not include those with advanced FTD.
Dyadic modelling was used to consider the capability
to live well in both people with dementia and carers and
to account for correlations within dyads. In addition to
relative differences across subtype, this study also reveals
baseline differences between people with dementia and
carers through this dyadic analysis approach. Capability
to live well was clearly not independent in these dyads,
but relative difference across subtype, a dyad-level meas-
ure, was not considerably affected by this correlation.
However, absolute scores on living well measures were
lower for carers than for people with dementia. Despite
variation across subtypes, baseline scores for life satisfac-
tion and wellbeing in carers were close to those for
participants with PDD and LBD, who had the worst
capability to live well. This indicates that carers generally
reported a poorer capability to live well than people with
dementia, regardless of subtype.
Clinical implications and future research directions
Variation in capability to live well was found across de-
mentia subtypes, particularly PDD and LBD. Guidelines
for dementia care may need to be tailored for different
subtypes and provide additional support for these
high-risk groups. Since the impact of living with VaD
and mixed AD/VaD may be related to comorbidity,
treatment of hypertension and vascular diseases is im-
portant for those with these subtypes. Health profes-
sionals who provide post-diagnostic support and care
may need to pay more attention to the PDD and LBD
subtypes and consider potential approaches to improve
quality of life and wellbeing for both people with demen-
tia and their carers [25]. In addition to medical treat-
ments, some non-pharmacological interventions might
support those living with PDD and LBD to maintain
daily function. For example, a recent pilot randomised
controlled trial focusing on 29 people with PDD and LBD
has suggested that cognitive rehabilitation, an individua-
lised approach addressing personally relevant goals, can
be effective in managing the impact of the cognitive diffi-
culties on daily life and in improving quality of life [26].
Future intervention studies may extend this approach to
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include the physical symptoms seen in PDD and LBD and
reduce the combined impact of cognitive and physical
symptoms on the capability to live well with these condi-
tions. Carers reported relatively low scores on living well
measures across all dementia subtypes. Burden of caregiv-
ing appears to be an important issue, and appropriate
support for family carers is vital [1].
To reduce the impact of subtype diagnosis, future
research may focus on identifying specific factors related
to the quality of life and wellbeing in PDD and LBD and
developing potential interventions to improve disease
management in people with dementia and carers. In
addition to medications, psychosocial and rehabilitative
interventions may play an important role in addressing
neuropsychiatric and behavioural symptoms and general
physical, psychological and social health [27].
Conclusions
The findings of this study suggest important differences
in the capability to live well across dementia subtypes.
Dementia care and health professionals who provide
post-diagnostic support should consider different needs
across subtypes, in particular the complex needs of
people living with PDD and LBD and their carers.
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in all people with dementia (N= 1363; adjusted for age, sex and type of
relationship). Table S2.2. The association between living well and subtypes in
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